Interview of Janet Rubin on Evenity

Time Line

• 00:00 – Introduction: Dr. Janet Rubin, Endocrinologist.
• 01:31– What is Evenity (Romosozumab)? Understanding monoclonal antibodies and anabolic drugs.
• 02:56 – Anabolic vs. Anti-resorptive: How Evenity differs from bisphosphonates and Prolia.
• 04:58 – The Science: How blocking sclerostin turns on bone formation.
• 06:33 – Administration: Monthly injections and the 12-month treatment cycle.
• 07:27 – Comparing Results: Evenity vs. Teriparatide vs. Alendronate for spine density.
• 11:10 – Insurance & Cost: Medical benefit vs. Pharmacy benefit coverage.
• 13:39 – What Comes Next? The importance of following Evenity with another drug (Prolia or Bisphosphonates).
• 16:16 – Re-Treatment: Can you use Evenity for a second course later in life?.
• 18:50 – Using "Drug Holidays" to clear metabolism before starting Evenity.
• 20:50 – The Ideal Patient: Why Dr. Rubin prioritizes Evenity for spine fractures.
• 24:06 – Should patients with very low bone density (without fractures) use Evenity?.
• 26:18 – Drug Half-Life: How long the medication stays in the system.
• 29:23 – Common Side Effects: Soreness and injection site reactions.
• 31:51 – Serious Safety Concerns: Addressing the cardiovascular "black box" warning and new real-world data.
• 36:25 – Questions to Ask Your Doctor: Why choose expensive anabolics over standard drugs?.
• 39:12 – Lifestyle & Exercise: Horseback riding and activity restrictions during treatment.